Patents Issued in November 9, 2017
-
Publication number: 20170319827Abstract: A low profile gripping device having a locking assembly attached to a base, wherein the locking assembly comprises a locking strap with pairs of fins disposed for insertion into an aperture of a buckle. The locking assembly comprises an anchor block having opposing sides, the locking strap attached to one side, and the buckle attached to the opposing side. The interface between the locking strap and the anchor block forms a creased groove for seating a flexible polymer tube or polymer coated cable. The locking strap is inserted through the aperture to secure the tube or cable in the creased groove, and the fins retain the locking strap in fixed relation to the buckle.Type: ApplicationFiled: July 24, 2017Publication date: November 9, 2017Inventors: James Alan Harders, Shawn Stone
-
Publication number: 20170319828Abstract: A wire lock assembly for an access port of an elongate medical tube includes a body having an exterior surface, an interior surface, and a central opening disposed therethrough, an attachment mechanism disposed through the exterior surface of the body, the attachment mechanism having an open end and a closed end, at least one notch arranged on the body and positioned proximate to the central opening and at least one seal supported within the interior surface of the body in communication with the central opening, the seal comprising a passageway therethrough, where the interior surface of the body defines a non-linear pathway for securing one or more medical devices.Type: ApplicationFiled: May 2, 2017Publication date: November 9, 2017Inventors: Bradley R. Doepker, Michelle D. Martinez, Tyler Evans McLawhorn, John C. Sigmon, JR., Shaun Gittard, Michael Brecht, Maximiliano Soetermans
-
Publication number: 20170319829Abstract: The present disclosure is directed toward a semi-compliant to non-compliant, conformable balloon useful in medical applications. Conformable balloons of the present disclosure exhibit a low straightening force when in a curved configuration and at inflation pressures greater than 4 atm. Balloons of the present disclosure are constructed of material that can compress along an inner length when the balloon is in a curved configuration. In further embodiments, balloons of the present disclosure can be constructed of material that sufficiently elongates along an outer arc when the balloon is in a curved configuration. As a result, medical balloons, in accordance with the present disclosure, when inflated in a curved configuration, exhibit kink-free configurations and do not cause a significant degree of vessel straightening.Type: ApplicationFiled: July 26, 2017Publication date: November 9, 2017Inventors: Carey V. Campbell, Matthew E. Maulding, Benjamin M. Trapp
-
Publication number: 20170319830Abstract: A combination wound drain and substance-delivery device includes a drain portion and a substance delivery portion. The drain portion and the substance-delivery portion include interior cavities that are separated from one another to prevent fluids and/or materials disposed within the interior cavities from mixing together. Each of the interior cavities includes one or more perforations that allow fluid communication between a wound site and each of the interior cavities. The device further includes a tip coupled to the drain portion that facilitates removal of collected waste from the drain portion. The device may include an attachment mechanism that helps secure the device when placed within a wound site.Type: ApplicationFiled: May 5, 2016Publication date: November 9, 2017Inventors: Richard J. Kana, Richard A. Hynes
-
Publication number: 20170319831Abstract: A high-strength steel sheet and a method for manufacturing a high-strength steel sheet having excellent phosphatability and excellent corrosion resistance after electrodeposition coating has been performed, even in the case where the contents of Si and Mn are high. The method may comprise annealing a steal sheet by using a continuous annealing method, performing a heating process, controlling the maximum end-point temperature of a steel sheet in the annealing furnace, controlling the traveling time of the steel sheet, and controlling the dew point of the atmosphere.Type: ApplicationFiled: July 24, 2017Publication date: November 9, 2017Applicant: RENISHAW (IRELAND) LIMITEDInventor: Steven S GILL
-
Publication number: 20170319832Abstract: A method, device, and kit for providing fluid to a patient, the device includes a food-contact-safe sponge and a handle, the handle supporting the sponge.Type: ApplicationFiled: August 12, 2016Publication date: November 9, 2017Inventor: Kelly Gardner
-
Publication number: 20170319833Abstract: Described herein is an intravaginal drug delivery system. In an embodiment the intravaginal drug delivery system includes a progestin and estrogen compound, and releases the active ingredients in a fixed physiological ratio over a prolonged period of time to produce a contraceptive state in a female.Type: ApplicationFiled: February 13, 2017Publication date: November 9, 2017Inventors: Ze'ev Shaked, Klaus Nickisch, James DiNunzio, Feng Zhang, Marcelo Omelczuk
-
Publication number: 20170319834Abstract: Retention devices and methods are provided for drug delivery. The device may include a housing configured for intraluminal deployment into a human or animal subject and at least one reservoir contained within the housing. The at least one reservoir may have an actuation end and a release end and contain at least one drug formulation. A plug may be contained within the at least one reservoir and be moveable from the actuation end toward the release end. The device may also include an actuation system operably connected to the actuation end of the at least one reservoir and configured to drive the at least one drug formulation from the reservoir. The device may also include at least one retention member affixed to the housing and movable between a non-stressed position, a deployment position, and a retention position for retaining the device in an intraluminal location in the subject.Type: ApplicationFiled: July 24, 2017Publication date: November 9, 2017Inventors: David Mathew Johnson, Martin Sheridan, Scott A. Uhland, Ramkumar Abhishek, Eric Peeters, Timothy J. Curley, Felicia Linn, Philipp H. Schmaelzle
-
Publication number: 20170319835Abstract: An apparatus for treating skin has a console with a user input device and a handpiece assembly. The handpiece assembly is configured to treat skin. A fluid line provides fluid communication between the console and the handpiece assembly. A manifold system is coupled to the console and controlled by the user input device. The manifold system is configured to hold releasably a plurality of fluid sources and deliver fluid from at least one of the plurality of fluid sources to the handpiece assembly.Type: ApplicationFiled: July 26, 2017Publication date: November 9, 2017Inventors: Roger Ignon, Scott Mallett, Abraham Solano, William Cohen
-
Publication number: 20170319836Abstract: An apparatus for treating skin has a console with a user input device and a handpiece assembly. The handpiece assembly is configured to treat skin. A fluid line provides fluid communication between the console and the handpiece assembly. A manifold system is coupled to the console and controlled by the user input device. The manifold system is configured to hold releasably a plurality of fluid sources and deliver fluid from at least one of the plurality of fluid sources to the handpiece assembly.Type: ApplicationFiled: July 26, 2017Publication date: November 9, 2017Inventors: Roger Ignon, Scott Mallett, Abraham Solano, William Cohen
-
Publication number: 20170319837Abstract: A single-piece, injection molded, hand-held liquid dispensing applicator. The single-piece applicator comprising a source of fluid and a frangible applicator tip attached to the fluid source. When the frangible applicator tip is broken, the fluid flows from the source to an absorbent member attached to the applicator tip to spread the liquid on a surface. The frangible tip may comprise a support element permanently connected to the fluid source, a relatively rigid tongue element, and a frangible region therebetween. The tongue element may comprise ribs for reinforcement. The frangible tip may comprise a semi-permeable or non-permeable cover to control the speed and direction of the dispersion of the fluid. The dispensing applicator may be used in various medical applications.Type: ApplicationFiled: April 10, 2017Publication date: November 9, 2017Applicant: BIOMED PACKAGING SYSTEMS INC.Inventors: JACK W. KAUFMAN, James Brown
-
Publication number: 20170319838Abstract: A liquid dispensing applicator may include a liquid source for housing a liquid, the liquid source having a first end and a second end, the second end being closed; a swab member for dispensing said liquid, the swab member being disposed at the first end; and at least one capillary member being in fluid communication with the liquid source, the capillary tube directing fluid out from the liquid source onto an exterior of the swab member upon application of pressure to the liquid source. A liquid dispensing applicator may also include an applicator tip fluidically connected to the liquid source including a frangible juncture and a tongue member coupled to the frangible junction, application of force to the tongue member causing the frangible junction to fracture while remaining attached to the tongue member, resulting in at least one aperture to form through which liquid from the liquid source is dischargeable.Type: ApplicationFiled: July 25, 2017Publication date: November 9, 2017Applicant: BIOMED PACKAGING SYSTEMS INC.Inventors: JACK W. KAUFMAN, James Brown
-
Publication number: 20170319839Abstract: A device that may be placed on a biological barrier can be used to perforate the biological barrier for a variety of purposes such as cosmetic, scar treatment or for the delivery of active agents. A flexible substrate has a first side and a second opposing side and a plurality of micro-penetrator arrangements each comprising a head and a first and second projection, for penetrating a biological barrier, extending from the head. The first and second projection at least partially extend through the flexible substrate towards the first side. The head comprises an elongate arm for spacing apart the first and second projections. A force is applied to the second side causing flexing of the flexible substrate and pushing the projections into communication with a biological barrier.Type: ApplicationFiled: November 25, 2015Publication date: November 9, 2017Inventor: Andrew James Kirby
-
Publication number: 20170319840Abstract: Described embodiments include a system, method, and apparatus. A system includes an extracellular-fluid collection device configured to be positioned at a location on a skin of a mammal. In an embodiment, the mammal includes a live human. The system includes an ultrasonic wave transmitter configured to emit ultrasonic shear waves directable at the location. The ultrasonic shear waves have a frequency or amplitude selected to increase a permeability of the skin of the mammal to an extracellular-fluid. In an embodiment, the system includes a sensor configured to determine a rate or amount of extracellular-fluid collected by the extracellular-fluid collection device. In an embodiment, the system includes a fluid collection controller configured to regulate a parameter of ultrasonic shear waves transmitted by the ultrasonic wave transmitter in response to a determined rate or amount of fluid collected by the extracellular-fluid collection device.Type: ApplicationFiled: May 9, 2016Publication date: November 9, 2017Inventors: JESSE R. CHEATHAM, III, JOEL CHERKIS, PAUL H. DIETZ, TOM DRISCOLL, WILLIAM GATES, RODERICK A. HYDE, MURIEL Y. ISHIKAWA, NEIL JORDAN, JORDIN T. KARE, ERIC C. LEUTHARDT, NATHAN P. MYHRVOLD, PATRICK NEILL, TONY S. PAN, ROBERT C. PETROSKI, DAVID R. SMITH, ELIZABETH A. SWEENEY, DESNY S. TAN, CLARENCE T. TEGREENE, DAVID LAWRENCE TENNENHOUSE, YAROSLAV A. URZHUMOV, GARY WACHOWICZ, LOWELL L. WOOD, JR., VICTORIA Y.H. WOOD
-
Publication number: 20170319841Abstract: Described embodiments include a system, method, and apparatus. A system includes a medicament-eluting device configured to be positioned at a location on a skin of a mammal. The system includes an ultrasonic wave transmitter configured to emit ultrasonic shear waves directable at the location. The ultrasonic shear waves have a frequency or amplitude selected to increase a permeability of the skin of the mammal to a medicament released by the medicament-eluting device. In an embodiment, the system includes a structure carrying the medicament-eluting device and the ultrasonic wave transmitter. In an embodiment, the system includes a cavitation sensor configured to detect a cavitation event in the mammal. In an embodiment, the system includes a cavitation controller configured to limit a power of the ultrasonic shear waves directed at the location to a level below a cavitation threshold of the mammal.Type: ApplicationFiled: May 9, 2016Publication date: November 9, 2017Inventors: JESSE R. CHEATHAM, III, JOEL CHERKIS, PAUL H. DIETZ, TOM DRISCOLL, WILLIAM GATES, RODERICK A. HYDE, MURIEL Y. ISHIKAWA, NEIL JORDAN, JORDIN T. KARE, ERIC C. LEUTHARDT, NATHAN P. MYHRVOLD, PATRICK NEILL, TONY S. PAN, ROBERT C. PETROSKI, DAVID R. SMITH, ELIZABETH A. SWEENEY, DESNY S. TAN, CLARENCE T. TEGREENE, DAVID LAWRENCE TENNENHOUSE, YAROSLAV A. URZHUMOV, GARY WACHOWICZ, LOWELL L. WOOD, JR., VICTORIA Y.H. WOOD
-
Publication number: 20170319842Abstract: An access port for providing subcutaneous access to a patient is disclosed. In one embodiment, the port includes an internal body defining a fluid cavity that is accessible via a septum. A compliant outer cover including silicone is disposed about at least a portion of the body. A flange is included with the port body and is covered by the outer cover. The flange radially extends about a perimeter of the port body proximate the septum so as to impede penetration of a needle substantially into the outer cover in instances where the needle misses the septum. The flange can further include both an anchoring feature for securing the outer cover to the port body and an identification feature observable via x-ray imaging technology for conveying information indicative of at least one attribute of the access port. The outer cover provides a suitable surface for application of an antimicrobial/antithrombotic coating.Type: ApplicationFiled: July 26, 2017Publication date: November 9, 2017Inventors: Martha R. Wiley, Jodie L. Noyce, David M. Cise, William R. Barron, Kelly J. Christian, Amir Orome
-
Publication number: 20170319843Abstract: A method and apparatus are provided for delivering an agent into a cell through the application of nanosecond pulse electric fields (“nsPEF's”). The method includes circuitry for delivery of an agent into a cell via known methods followed by the application of nanosecond pulse electric fields to said cell in order to facilitate entry of the agent into the nucleus of the cell. In a preferred embodiment, the present invention is directed to a method of enhancing gene expression in a cell comprising the application of nanosecond pulse electric fields to said cell. An apparatus for generating long and short pulses according to the present invention is also provided. The apparatus includes a pulse generator capable of producing a first pulse having a long duration and low voltage amplitude and a second pulse having a short duration and high voltage amplitude.Type: ApplicationFiled: July 19, 2017Publication date: November 9, 2017Inventors: Stephen J. BEEBE, Karl H. SCHOENBACH
-
Publication number: 20170319844Abstract: The present invention relates to a wearable band for low frequency therapy and, more specifically, to a wearable band for low frequency therapy, the wearable band enabling a wearer to connect to a low frequency therapy device while wearing, on a body part, a cylindrical wearable band in which knitted pile yarn is formed from conductive fiber, thereby providing low-frequency stimulation to the part of the wearer's body such that the wearer can receive physical therapy.Type: ApplicationFiled: December 10, 2015Publication date: November 9, 2017Inventors: Dae-Ki WOO, Byong-No WOO
-
Publication number: 20170319845Abstract: Tunneling tools and systems comprising electrodes and tunneling tool. In some examples the tunneling tools have a width that is greater than thickness, or may have enlarged portions to allow tunneling of a space. The tunneling tools may have expandable dissection portions including expandable balloons, linkages and/or springs in different examples. Systems may include tunneling tools with a lumen for receiving a lead having an electrode in a collapsed configuration, where the electrode is designed to expand once placed in a patient, with the tunneling tool designed to create a space in which the electrode can expand.Type: ApplicationFiled: May 4, 2017Publication date: November 9, 2017Applicant: CARDIAC PACEMAKERS, INC.Inventors: ANDREW L. DE KOCK, G. SHANTANU REDDY, ROBERT D. BROCK, II, STEPHEN J. HAHN, BRENDAN E. KOOP, MOIRA B. SWEENEY, WYATT K. STAHL
-
Publication number: 20170319846Abstract: An implantable electrode arrangement provides spatially-selective detection of neuronal electrical signals, which propagate along at least one nerve fiber contained in a nerve fascicle, and for selective electrical stimulation of the at least one nerve fiber, comprising a biocompatible carrier substrate, which has at least one carrier substrate region that can be placed around the nerve fascicle in a cuff and has a straight cylinder-shaped carrier substrate surface which faces the nerve fascicle in the implanted state. The carrier substrate surface has an axial extension and an extension oriented circumferentially in a direction and a first electrode arrangement attached thereto.Type: ApplicationFiled: October 7, 2015Publication date: November 9, 2017Inventors: Dennis PLACHTA, Mortimer GIEHRTMUEHLEN, Thomas STIEGLITZ, Josef ZENTNER
-
Publication number: 20170319847Abstract: A device for loading a leadless pacemaker onto a catheter-based delivery system includes a distal portion and a proximal portion. The distal portion includes a retention feature configured to receive the leadless pacemaker. The proximal portion is proximal the distal portion and includes a funneling structure opening toward the retention feature. The distal and proximal portions of the device are configured such that, when a distal end of the catheter-based delivery system is brought towards the proximal portion of the loading device and the leadless pacemaker is retained by the retention feature, the funneling structure guides features of the distal end of the catheter-based delivery system through an opening in an attachment feature located at a proximal end of the leadless pacemaker.Type: ApplicationFiled: April 26, 2017Publication date: November 9, 2017Inventors: Friedrich Ho, Thomas B. Eby, Paul Paspa
-
Publication number: 20170319848Abstract: Systems and methods for gastrointestinal electrical stimulation to treat abnormalities in gastrointestinal motility are provided. In some embodiments, a system for relieving ileus includes an intraluminal catheter comprising: a catheter body having a proximal tip and a distal tip and a duodenal portion proximal to the distal tip of the catheter; and at least one electrode pair disposed along the duodenal portion of the intraluminal catheter, the at least one electrode pair being configured to detect a sensing information indicative of myoelectric activity of a patient and to provide stimulation energy; a sensing system in communication with the at least one electrode pair to receive the sensing information; and an energy delivery system in communication with the at least one electrode pair and the sensing system, the electrical energy delivery system being configured to delivery energy to the patient through the at least one second electrode pair based on the sensing information from the sensing system.Type: ApplicationFiled: July 26, 2017Publication date: November 9, 2017Inventors: Andy H. Levine, Michael Partsch, Jay Pasricha, Jiande Chen
-
Publication number: 20170319849Abstract: In some examples, electrical stimulation is delivered to a patient such that selective termination of the stimulation causes a therapeutic effect in the patient after termination of the electrical stimulation to the patient. The electrical stimulation may be insufficient to produce a desired therapeutic effect in the patient during stimulation, but sufficient to induce a post-stimulation desired therapeutic effect following termination of the stimulation. In some examples, the electrical stimulation may be sub-threshold electrical stimulation. In some examples, the desired therapeutic effect may alleviate bladder dysfunction, bowel dysfunction, or other disorders. The stimulation may be selectively terminated in response to one or more therapy trigger events to induce the post-stimulation therapeutic effect.Type: ApplicationFiled: July 27, 2017Publication date: November 9, 2017Inventors: Xin Su, Dwight E. Nelson
-
Publication number: 20170319850Abstract: A method of providing therapeutic regimens includes encoding a plurality of treatment regimens each in a treatment digital file, a treatment regimen of the plurality including a plurality of simultaneous frequency signals; and distributing the plurality of treatment regimens to a file marketplace. A method for treating a patient includes encoding a therapeutic frequency in a file to be stored on a device having an audio jack with sufficient capabilities to deliver the specific treatment, applying electrodes connected to the device through the audio jack to the patient, and applying the treatment with the device. The therapeutic frequencies are applied to the patient as electrical energy waves.Type: ApplicationFiled: May 5, 2017Publication date: November 9, 2017Inventor: Hans Thomas Meyer
-
Publication number: 20170319851Abstract: A method of testing a therapeutic pulse generator circuit is disclosed. The method includes charging the pulse generator circuit to a first charge voltage, with the pulse generator circuit, delivering a first voltage pulse to a load through an electrode, and determining an impedance of the load with the first voltage pulse. The method also includes comparing the impedance with an expected impedance, as a result of the comparison, determining to deliver a second voltage pulse to the load based, and delivering the second voltage pulse to the load, where at least one of the first and second voltage pulses is therapeutic to the load.Type: ApplicationFiled: November 9, 2016Publication date: November 9, 2017Applicant: Pulse Biosciences, Inc.Inventors: Brian G. Athos, David J. Danitz, Mark P. Kreis, Darrin R. Uecker
-
Publication number: 20170319852Abstract: A method for providing electrical stimulation to a user as a user performs a set of tasks during a time window, the method comprising: providing an electrical stimulation treatment, characterized by a stimulation parameter and a set of portions, to a brain region of the user in association with the time window; for each task of the set of tasks: receiving a signal stream characterizing a neurological state of the user; from the signal stream, identifying a neurological signature characterizing the neurological state associated with the task; and modulating the electrical stimulation treatment provided to the brain region of the user based upon the neurological signature, wherein modulating comprises delivering a portion of the set of portions of the electrical stimulation treatment to the brain region of the user, while maintaining an aggregate amount of the stimulation parameter of the treatment provided during the time window below a maximum limit.Type: ApplicationFiled: July 24, 2017Publication date: November 9, 2017Inventors: Brett Wingeier, Daniel S. Chao, Lee Von Kraus, Amol Sarva, Sophia Sanchez
-
Publication number: 20170319853Abstract: Endovascular nerve monitoring devices and associated systems and methods are disclosed herein. A nerve monitoring system configured in accordance with a particular embodiment of the present technology can include a shaft having a proximal portion and a distal portion and a nerve monitoring assembly at the distal portion. The shaft is configured to locate the distal portion intravascularly at a treatment site. The nerve monitoring assembly can include a bipolar stimulation electrode array and a bipolar recording electrode array disposed distal to the bipolar stimulation electrode assembly.Type: ApplicationFiled: May 12, 2017Publication date: November 9, 2017Inventors: Dwayne S. Yamasaki, Bryan Courtney, Wenjeng Li, Kevin Mauch, Kevin McFarlin, Gabriel Brennan, David Gannon, David Hobbins, Brian Kelly, Stephen Nash, Matthew Bonner, Sean Ward
-
Publication number: 20170319854Abstract: Systems and methods are provided for delivering neurostimulation therapies to patients for treating chronic heart failure. A neural fulcrum zone is identified and ongoing neurostimulation therapy is delivered within the neural fulcrum zone. This neural fulcrum zone corresponds to a combination of stimulation parameters at which autonomic engagement is achieved, while the tachycardia-inducing stimulation effects are offset by the bradycardia-inducing effects, thereby minimizing side effects such as significant heart rate changes while providing a therapeutic level of stimulation.Type: ApplicationFiled: May 19, 2017Publication date: November 9, 2017Applicants: CYBERONICS, INC., EAST TENNESSEE STATE UNIVERSITYInventors: Bruce H. KenKnight, Jeffrey L. Ardell, Imad Libbus, Badri Amurthur
-
Publication number: 20170319855Abstract: In various method embodiments for operating an implantable neural stimulator to deliver a neural stimulation therapy to an autonomic neural target, the method comprises using the implantable neural stimulator to deliver the neural stimulation therapy to the autonomic neural target, and evaluating an evoked response to the neural stimulation bursts. The neural stimulation therapy includes a plurality of neural stimulation bursts where each neural stimulation burst includes a plurality of neural stimulation pulses and successive neural stimulation bursts are separated by a time without neural stimulation pulses. Evaluating the evoked response includes sensing the evoked response to the neural stimulation bursts where sensing the evoked response includes sensing at least one physiological parameter affected by the neural stimulation bursts, comparing the sensed evoked response against a baseline, and determining if the evoked response substantially returns to the baseline between neural stimulation bursts.Type: ApplicationFiled: July 26, 2017Publication date: November 9, 2017Inventors: Andrew P. Kramer, Jason J. Hamann
-
Publication number: 20170319856Abstract: An example of a system may include an arrangement of electrodes configured to be operationally positioned for use in modulating targeted neural tissue, a neural modulator, a communication module, and a controller. The neural modulator may be configured to use at least some electrodes within the arrangement of electrodes to generate a modulation field. The communication module may be configured to receive user-provided selections. The controller may be configured to use the communication module to receive a user-provided selection of a desired electrode list where the electrode list identifies electrodes within the arrangement of electrodes that are available for use in modulating the targeted neural tissue, control the neural stimulation modulator to generate the modulation field, and use the electrodes identified in the electrode list to modulate the targeted neural tissue.Type: ApplicationFiled: May 22, 2017Publication date: November 9, 2017Inventors: Michael A. Moffitt, Bradley Lawrence Hershey, Changfang Zhu, Jordi Parramon, Sridhar Kothandaraman
-
Publication number: 20170319857Abstract: An implantable medical device implements a special mode of operation, such as a mode of electrical stimulation therapy, during conditions where there may be an increased likelihood that a device reset will occur. The implantable medical device recovers from the device reset by copying values that specify the special mode and that are stored in a non-volatile memory to an operating memory. The special mode is implemented after the device reset has occurred by using the values copied to the operating memory. One version of the special mode is an MRI mode that allows the implantable medical device to safely operate during an MRI scan. The fields of the MRI scan may trigger a device reset, but the MRI mode values are copied from the non-volatile memory to the operating memory, and the MRI mode is implemented after the reset by using the values copied to the operating memory.Type: ApplicationFiled: July 28, 2017Publication date: November 9, 2017Inventors: Troy A. JENISON, Michael D. LEVY, Benjamin P. RHODES, Christopher C. STANCER
-
Publication number: 20170319858Abstract: A system for providing energy to a bio-implantable medical device includes an acoustic energy delivery device and a bio-implantable electroacoustical energy converter. The acoustic energy delivery device generates acoustic energy with a multi-dimensional array of transmitting electroacoustical transducers. The acoustic energy is received by one or more receiving electroacoustical transducers in the bio-implantable electroacoustical energy converter. The receiving electroacoustical transducers convert the acoustic energy to electrical energy to power the bio-implantable medical device directly or indirectly. An external alignment system provides lateral and/or angular positioning of an ultrasound energy transmitter over an ultrasound energy receiver. The acoustic energy transmitter alignment system comprises either or both x-y-z plus angular positioning components, and/or a substantially multi-dimensional array of transmitters plus position sensors in both the transmitter and receiver units.Type: ApplicationFiled: May 5, 2017Publication date: November 9, 2017Inventors: Leon J. Radziemski, Inder Raj Singh Makin, Harry Jabs, Juan Carlos Lopez Tonazzi
-
Publication number: 20170319859Abstract: Methods and devices for providing noninvasive electrotherapy and electrical stimulation are described herein. In one aspect, a device for noninvasive electrotherapy includes wireless communication circuitry configured to receive pulse generation control signals wirelessly transmitted from a computing device. The device can include pulse generation circuitry configured to deliver electrical waveforms according to instructions encoded in the pulse generation control signals. The computing device can include a cellular telephone device, a portable media player, a personal digital assistant, a tablet computer, or an internet access device.Type: ApplicationFiled: April 24, 2017Publication date: November 9, 2017Inventors: Thomas Jerome Bachinski, Michael Wayne Moore, Joseph Winn, Jay Dave, David Orr, Dain Silvola
-
Publication number: 20170319860Abstract: A programming-device user interface may include multiple levels of abstraction for programming treatment settings. A stimulation zone-programming interface may be at a highest level of abstraction and may include idealized stimulation zones. A field strength-programming interface may be at a middle level of abstraction and may include electromagnetic field-strength patterns generated by the stimulation zones, and/or electrode settings, and a depiction of how the electromagnetic fields interact with each other. An electrode-programming interface may be at a lowest level of abstraction and may depict treatment settings at an electrodes-view level. These interfaces may include a display of a stimulatable area of the patient's body. The display may include a depiction of leads and/or the underlying physiology, such as a depiction of a portion of a spine. Algorithms map treatment settings from one level of abstraction to settings at one or more other levels of abstraction.Type: ApplicationFiled: May 22, 2017Publication date: November 9, 2017Inventor: Steven M. Goetz
-
Publication number: 20170319861Abstract: Systems and methods that include configurations of a medical device, user device and service platform are described. Embodiments may include a secure network to run medical applications that control and/or monitor the medical device. An online store may be provided for storing and distributing medical applications to the user device and medical device. A secure environment may be provided within the user device and medical device that protects the integrity of medical applications running on those devices. A service platform may provide a service that enables a medical authority to certify and monitor the medical applications. In some implementations, various third parties and the user of the user device may be allowed to manage and monitor the medical device.Type: ApplicationFiled: April 18, 2017Publication date: November 9, 2017Inventor: Michael Golden
-
Publication number: 20170319862Abstract: A wearable cardioverter defibrillator (“WCD”) system may output a loud sound after detecting and validating a shockable cardiac arrhythmia. In such embodiments, however, the WCD system might not sound a loud alarm before validating the arrhythmia thoroughly, i.e. for a longer time, thus giving the arrhythmia a further chance to self-terminate. The WCD system may thus detect more robustly the cardiac arrhythmias that do not self-terminate quickly. Such arrhythmias that self-terminate quickly may occur from likely harmless events occurring multiple times in the daily life of the patient, such as the patient becoming “winded” from climbing stairs. In embodiments the WCD system may notify the patient only discreetly, or even not at all. The lack of sounding such a loud alarm responsive to such events reduces the overall number of times in which the patient experiences unwanted attention by others, embarrassment, loss of privacy and dignity, and so on.Type: ApplicationFiled: July 12, 2017Publication date: November 9, 2017Inventors: Phillip D. Foshee, JR., David P. Finch, Laura M. Gustavson, Nikolai Korsun, Joseph L. Sullivan
-
Publication number: 20170319863Abstract: Implantable cardiac systems and methods for providing substernal pacing in an ICD system are described. In one example, an implantable cardiac system comprises an ICD system and an implantable leadless pacing device (LPD) communicatively coupled to the ICD system. The ICD system includes an ICD and an implantable defibrillation lead having a proximal portion coupled to the ICD and a distal portion having a defibrillation electrode configured to deliver a defibrillation shock to a heart of the patient. The LPD includes a housing, a first electrode on the housing, a second electrode on the housing, and a pulse generator within the housing and electrically coupled to the first electrode and the second electrode. The housing of the LPD is implanted substantially within an anterior mediastinum of the patient and the pulse generator is configured to deliver pacing pulses to a heart via the first and second electrodes.Type: ApplicationFiled: July 27, 2017Publication date: November 9, 2017Inventors: Amy E. THOMPSON-NAUMAN, Melissa G.T. CHRISTIE, Paul J. DEGROOT, Rick D. MCVENES
-
Publication number: 20170319864Abstract: A subcutaneous implantable cardioverter-defibrillator (S-ICD) comprising shocking electrodes configured to reduce the defibrillation threshold. The S-ICD may include a canister housing a source of electrical energy, a capacitor, and operational circuitry that senses heart rhythms and an electrode and lead assembly. The electrode and lead assembly may comprise a lead, at least one sensing electrode, and at least one shocking electrode. The at least one shocking electrode may extend over a length in the range of 50 to 110 millimeters and a width in the range of 1 to 40 millimeters.Type: ApplicationFiled: May 4, 2017Publication date: November 9, 2017Applicant: CARDIAC PACEMAKERS, INC.Inventors: ANDREW L. DE KOCK, G. SHANTANU REDDY, ROBERT D. BROCK, II, STEPHEN J. HAHN, BRENDAN E. KOOP, MOIRA B. SWEENEY, WYATT K. STAHL
-
Publication number: 20170319865Abstract: The current technology relates to a shock deferral unit that is portable by an ambulatory patient. The shock deferral unit has a bi-directional communication device configured to receive a notification of an impending shock from a defibrillator and configured to send an instruction to defer the impending shock to the defibrillator. An authentication interface is configured to receive authentication data from a user. A user instruction interface is configured to receive the instruction to defer the impending shock from the user. An authentication device is configured to authenticate the user based on the authentication data and instruct the bi-directional communication device to send the instruction to defer a shock upon authentication and receipt of the instruction to defer the shock.Type: ApplicationFiled: May 2, 2017Publication date: November 9, 2017Inventors: Jeffrey E. Stahmann, Dan C. Goldman
-
Publication number: 20170319866Abstract: A multi-functional airbag comprises a main body, a front side of the main body is provided with an opening, a rear side of the main body opposite to the opening is provided with a functional cavity to install a functional assembly, a left air chamber and a right air chamber communicated with each other are symmetrically configured at two sides of the main body, and the functional assembly is installed in the functional cavity. While in use, the air chambers are inflated, as a result the main body is inflated to enable to clamp two sides of the human neck; while not in use, the air chambers are deflated to reduce the volume to make it portable. Meanwhile, massage functioning members are configured to massage the acupuncture points by vibration therapy, pulse therapy, heat therapy, infrared light therapy, and/or magnet therapy, and the therapy effect is obvious.Type: ApplicationFiled: June 30, 2017Publication date: November 9, 2017Inventor: Zhiming Liu
-
Publication number: 20170319867Abstract: A bone implant includes a rod having an aperture extending entirely through the rod. The aperture is to receive a fastener to couple the rod to a bone of a patient. The bone implant also includes a light source disposed on the rod. The light source is to emit light onto a portion of the bone adjacent the rod to at least one of stimulate bone growth or reduce bone loss.Type: ApplicationFiled: February 27, 2017Publication date: November 9, 2017Inventors: James T. Ninomiya, Janine A. Struve, Dorothee Weihrauch, Scott Howard Micoley, Dale Selsor DiIulio, Douglas J. Birkholz, Kyle Steven Jansson, Richard B. Davidson
-
Publication number: 20170319868Abstract: A system and method for light stimulation within a medium. The system has a reduced-voltage x-ray source configured to generate x-rays from a peak applied cathode voltage at or below 105 kVp, and a plurality of energy-emitting particles in the medium which, upon radiation from the x-ray source, radiate at a first lower energy than the x-ray source to interact with at least one photoactivatable agent in the medium. The method introduces the plurality of energy-emitting particles into the medium, radiates the energy-emitting particles in the medium with x-rays generated from a peak applied cathode voltage at or below 105 kVp; and emits a lower energy than the x-ray source to interact with the medium or with at least one photoactivatable agent in the medium.Type: ApplicationFiled: July 14, 2017Publication date: November 9, 2017Applicants: IMMUNOLIGHT, LLC., DUKE UNIVERSITYInventors: Frederic A. Bourke, JR., Harold Walder, Zakaryae Fathi, Michael J. Therien, Mark W. Dewhirst, Ian N. Stanton, Jennifer Ann Ayres, Diane Renee Fels, Joseph A. Herbert
-
Publication number: 20170319869Abstract: A system and method for light stimulation within a medium. Products, compositions, systems, and methods for modifying a target structure which mediates or is associated with a biological activity, including treatment of conditions, disorders, or diseases mediated by or associated with a target structure, such as a virus, cell, subcellular structure or extracellular structure. The methods may be performed in situ in a non-invasive manner by application of an initiation energy to a subject thus producing an effect on or change to the target structure directly or via a modulation agent. The methods may further be performed by application of an initiation energy to a subject in situ to activate a pharmaceutical agent directly or via an energy modulation agent, thus producing an effect on or change to the target structure. Kits containing products or compositions formulated or configured and systems for use in practicing these methods.Type: ApplicationFiled: July 14, 2017Publication date: November 9, 2017Applicant: IMMUNOLIGHT, LLC.Inventors: Frederic A. BOURKE, JR., Harold Walder
-
Publication number: 20170319870Abstract: The present invention relates to a method of preventing or reducing one or more adverse post-anaesthetic effects in a patient, comprising treating the patient with low level laser therapy (LLLT) prior to anaesthesia and/or during anaesthesia and/or following anaesthesia, and to a method for assessing whether a patient is at risk of suffering from adverse post-anaesthetic effects, comprising determining whether the patient contains a polymorphism in a gene encoding one of the following proteins: (a) protein associated with assembly and disassembly of microtubules; (b)ion channel protein; (c) membrane stability protein; (d) Melanocortin systems proteins; (e) proteins associated with Alzheimer's and/or Parkinson's vulnerability; or (f) proteins associated with migraine.Type: ApplicationFiled: November 12, 2015Publication date: November 9, 2017Inventors: Ann LIEBERT, Roberta CHOW, Euahna VARIGOS
-
Publication number: 20170319871Abstract: A mechanism facilitates the insertion of radioactive sources/source strands into soft tissue, such as breast tissue, that improves the reproducibility of the procedure and ensures that the sources are reliably and consistently inserted in an exact position per a patient prescription treatment plan from patient to patient as well as improve the ease-of-use of the device and procedure.Type: ApplicationFiled: July 21, 2017Publication date: November 9, 2017Inventor: Charlie PITMAN
-
Publication number: 20170319872Abstract: A particle beam detector system can comprise a particle beam generator, a particle beam fluence and position detector array based on Micromegas technology, and data readout electronics coupled to the position detector array. The particle beam fluence and position detector array can comprise a sealed, gas-filled, ionizing radiation detector chamber. A printed circuit board (PCB) can be disposed within the ionizing radiation detector chamber, the PCB comprising a multi-layer array arrangement of interconnected conductive sensor pads comprising three planar coordinate grids, X, Y, and ST (stereo) situated on separate layers of the PCB. The multi-layer array arrangement of interconnected conductive sensor pads can comprise a first footprint. A dielectric lattice structure can be disposed over the PCB and the multi-layer array arrangement of sensors. A conductive mesh structure can comprise a second footprint disposed over the dielectric lattice structure and extending over an entire area of the first footprint.Type: ApplicationFiled: May 8, 2017Publication date: November 9, 2017Inventor: Evgeny Galyaev
-
Publication number: 20170319873Abstract: A control system for providing a closed loop, real time control of a charged particle pencil beam is disclosed. The system includes a first detector apparatus, a second detector apparatus, a first orthogonal magnetic deflector apparatus, a second orthogonal magnetic deflector apparatus, and a controller. The controller compares the measured position and beam angle of the beam with a model position and beam angle of a model beam to determine an offset error and a beam angle error. The first orthogonal magnetic deflector apparatus includes a pair of electromagnets to correct a first component of the offset and beam angle errors. The second orthogonal magnetic deflector apparatus includes a pair of electromagnets to correct a second component of the offset and beam angle errors. The beam can be iteratively adjusted during patient therapy or short pauses in patient therapy.Type: ApplicationFiled: May 4, 2016Publication date: November 9, 2017Inventors: Raymond Paul Boisseau, John Gordon, William P. Nett, Kan Ota
-
Publication number: 20170319874Abstract: Some embodiments are directed to an image director of a patient monitoring system to obtain calibration images of a calibration sheet or other calibration object at various orientations and locations. The images are then stored and processed to calculate camera parameters defining the location and orientation of the image detector and identifying internal characteristics of the image detector, and the information are stored. The patient monitoring system can be re-calibrated by using the image detector to obtain an additional image of a calibration sheet or calibration object. The additional image and the stored camera parameters are then used to detect any apparent change in the internal characteristics of the image detector (10) (S6-4).Type: ApplicationFiled: November 9, 2015Publication date: November 9, 2017Inventors: Edward William MEAD, Ivan Daniel MEIR
-
Publication number: 20170319875Abstract: A method for delivering therapeutic ultrasound to a patient to ensure full treatment of targeted tissue can include performing preoperative imaging of a first volume of targeted tissue of a patient using an ultrasound probe and creating a first treatment plan. Energy can be delivered into at least a distal portion of the first volume. The amount of energy delivered can be sufficient to produce swelling of tissue in the first volume. The first volume can be reimaged to identify if any changes have occurred in at least one of a size, shape and location of the first volume of the targeted tissue. A second treatment plan can be designed to treat a second volume of tissue equivalent to the changed first volume of targeted tissue. Energy can be delivered into the second volume of the targeted tissue.Type: ApplicationFiled: May 3, 2017Publication date: November 9, 2017Inventors: Mark Carol, Hashim U. Ahmed
-
Publication number: 20170319876Abstract: A hair-cleaning agent includes (in relation to the total weight thereof): a) between 6 and 12 wt. % at least one anionic surfactant; b) between 0.1 and 5 wt. % at least one non-ionic surfactant; c) between 0.01 and 2 wt. % at least one cationic conditioning polymer; and d) (i) between 0.01 and 3 wt. % calcium lactate or (ii) between 0.1 and 5 wt. % lactic arid and between 0.05 and 3 wt. % at least one inorganic calcium salt; and a pH value in the region between 4.3 and 5.0. The hair-cleaning agent is suitable for improving de-tangling properties and combability, as well as reducing electrostatic charging (flyaway hairs) and the occurrence of unruly hair or unwanted crimped hairs (anti-frizz effect), in particular for damaged hair.Type: ApplicationFiled: February 27, 2017Publication date: November 9, 2017Applicant: Henkel AG & Co, KGaAInventors: Dirk Hentrich, Corinna Bender